NCT02215486

Brief Summary

The autonomic nervous system (ANS) unconsciously regulates the activities of vital organ systems such as the respiratory, circulatory, and urinary systems. It consists of two major components, the parasympathetic nervous system (PNS) and the sympathetic nervous system (SNS), which together are in charge of keeping our body in homeostasis. Homeostasis is the state of chemical and metabolic balance within an organism; it is disturbed in situations of uncontrolled stress. Massage has been shown to decrease SNS and stimulate PNS; but most studies focused on full body massage, with limited assessment of ANS function, and lacked control groups. The effects of head massage therapy (HMT) on regulating the activity of the ANS have not been studied before. In this pilot study, we propose that by randomizing 10 participants to sessions of HMT and 'Simple Relaxation' (no HMT), and by using a non-invasive method of measuring the ANS activity (spectral analysis of Heart Rate Variability \[HRV\] as well as Pre-ejection Period (PEP)), we will be able to investigate the effects of 10 minutes of HMT in comparison with the period of no HMT administered. We expect HMT to reduce stress, with a better and balanced profile of autonomic nervous system after receiving massage.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 9, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 13, 2014

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Last Updated

May 28, 2015

Status Verified

May 1, 2015

Enrollment Period

5 months

First QC Date

August 9, 2014

Last Update Submit

May 26, 2015

Conditions

Keywords

Head massage therapyMassage therapyAutonomic nervous system (ANS)Heart rate variability (HRV)Pre-ejection period (PEP)

Outcome Measures

Primary Outcomes (2)

  • Heart Rate Variability (HRV) parameters

    Main HRV parameters that will be reported include High Frequency (HF) which is the power in high frequency range representative of the parasympathetic nervous system activity, HFnu which is the HF power in normalized units, and total power which is the total variability of the autonomic nervous system over the temporal segment. HRV parameters are measured at baseline and post intervention. Post-intervention outcomes for each subject will be compared with their baseline. There will also be comparison of the outcomes between the massage and the control intervention, for the effect of massage therapy

    Within 1 day

  • Pre-ejection period (PEP)

    PEP is the time interval between electrical stimulation of the sinoatrial node and opening of the aortic valves and has shown to be inversely correlated with the activity of the sympathetic nervous system. PEP is measured at baseline and post intervention. Post-intervention outcomes for each subject will be compared with their baseline. There will also be comparison of the outcomes between the massage and the control intervention, for the effect of massage therapy.

    Within 1 day

Interventions

Intervention consists of administering head massage therapy according to the Chinese head massage protocol for approximately 10 minutes.

Consists of a simple relaxation in the same sitting position as the head massage therapy session.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Otherwise healthy individuals

You may not qualify if:

  • Use of anti-depressants or drugs that affect the cardiovascular system or ANS
  • Smoking more than 10 cigarettes/day
  • Inability to provide consent
  • Inability to speak and/or understand English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BC Children's and Women's Hospital

Vancouver, British Columbia, V6H 3N1, Canada

Location

Study Officials

  • Jean-Paul Collet, MD, PhD

    Children's & Women's Health Centre of British Columbia

    PRINCIPAL INVESTIGATOR
  • Mir Sohail Fazeli, M.D.

    The University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

August 9, 2014

First Posted

August 13, 2014

Study Start

April 1, 2014

Primary Completion

September 1, 2014

Last Updated

May 28, 2015

Record last verified: 2015-05

Locations